medigraphic.com

2018, Número 4

<< Anterior Siguiente >>

Enf Infec Microbiol 2018; 38 (4)


Melioidosis en pediatría: potencial agente de bioterrorismo microbiológico

López CG, López DAV, Reyes HKL, Reyes GU, Santos CLA, De Lara HJ, Quero HA, Matos ALJ, Martínez APA, Luevanos VA

Idioma: Español
Referencias bibliográficas: 63
Paginas: 131-137
Archivo PDF: 227.97 Kb.


RESUMEN

La melioidosis es una enfermedad tropical ocasionada por el bacilo Gram-negativo Burkholderia pseudomallei, transmitido a través del suelo, es una enfermedad endémica en el norte de Australia y en el sureste asiático, y actualmente se reconoce en lugares no endémicos, incluido México. El género Burkholderia comprende más de 40 especies.
El presente trabajo es una revisión de conceptos elementales para la sospecha clínica y el diagnóstico por laboratorio, para establecer un manejo oportuno dada su alta mortalidad. El cuadro clínico es muy similar a tuberculosis, sepsis fulminante o neumonía de evolución rápida. Por su alta letalidad, existe un gran riesgo de que éste se haya utilizado en bioterrorismo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Martínez-Hernández, L., González-Híjar, A., Valdez-Vásquez, R., García-López, S. y González-Chon, O., “Melioidosis: reporte de un caso y revisión de la literatura”, Neumol Cir Torax, 2013, 72 (4): 291-298.

  2. Sarovich, D.S., Chapple, S.N., Price, E.P., Matthew, M.M., Holden, T.G., Peacock, S.J. y Currie, B.J., “Whole-genome sequence to investigate a non-clonal melioidosis cluster on a remote Australian island”, Microbial Genomics, 2017, 3: 1-7.

  3. Mukhopadhyay, C., Eshwara, V.K., Kini, P. y Bhat, V., “Pediatric melioidosis in Southern India”, Indian Pediatr, 2015, 52: 711-712.

  4. Baker, C.J., Red Book. Atlas of pediatric infectious diseases. 3ª ed., American Academy of Pediatrics, 2015.

  5. Hayden, H.S. et al., “Evolution of Burkholderia pseudomallei in recurrent melioidosis, plos One, 2012, 7: e36507, disponible en: https://doi.org/10.1371/journal. pone.0036507.

  6. Price, E.P. et al., “Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis, plos Pathog, 2010, 6: e1000725, disponible en: https://doi. org/10.1371/journal.ppat.1000725.

  7. Lever, M.S. et al., “Experimental aerogenic Burkholderia mallei (glanders) infection in the balb/c mouse”, J Med Microbiol, 2003, 52: 1109-1115.

  8. Zeeshan, M., Aziz, T. y Naqvi, F., “Recurrent urinary tract infection by Burkholderia cepacia in a live related renal transplant recipient”, J Pak Med Assoc, 2012, 62: 496-498.

  9. De Souza, A. et al., “Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience”, J Heart Lung Transplant, 2010, 29: 1395-1404.

  10. Gilad, J., Schwartz, D. y Amsalem, Y., “Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseudomallei, ijbs, 2007, 3 (3): 144-152.

  11. Singh, M. y Mahmood, M., “Melioidosis: the great mimicker”, J Community Hosp Intern Med Perspect, 2017, 7 (4): 245-247.

  12. Hoffmaster, A.R., Aucoin, D., Baccam, P. et al., “Melioidosis diagnostic workshop, 2013”, Emerg Infect Dis, 2015, 21 (2): e141045.

  13. Merritt, A.J. y Inglis, T.J.J., “The role of climate in the epidemiology of melioidosis”, Curr Trop Med Rep, 2017, 4 (4): 185-191.

  14. Currie, B.J., Burkholderia pseudomallei and Burkholderia mallei: melioidosis and glanders, en Bennett, J.E., Dolin, R. y Blaser, M.J. (eds.), Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, PA, Elsevier Saunders, 2015, pp. 2541-2551.

  15. Stewart, T., Engelthaler, D.M., Blaney, D.D. et al., “Epidemiology and investigation of melioidosis, Southern Arizona”, Emerg Infect Dis, 2011, 17: 1286-1288.

  16. Centers for Disease Control and Prevention (cdc), “Imported melioidosis–South Florida, 2005”, mmwr Morb Mortal Wkly Rep, 2006, 55: 873.

  17. Yee, K.C., Lee, M.K., Chua, C.T. et al., “Melioidosis, the great mimicker: a report of 10 cases from Malaysia”, J Trop Med Hyg, 1988, 91: 249-254.

  18. Bandeira, T.J.P.G., Castelo-Branco, D.S.C.M., Rocha, M.F.G., Cordeiro, R.A., Ocadaque, C.J., Paiva, M.A.N., Brilhante, R.S.N. y Sidrim, J.J.C., “Clinical and environmental isolates of Burkholderia pseudomallei from Brazil: genotyping and detection of virulence gene”, Asian Pac J Trop Med, 2017, 10 (10): 945-951.

  19. Wiersinga, W.J., Currie, B.J. y Peacock, S.J., “Melioidosis”, N Engl J Med, 2012, 367: 1035-1044.

  20. Robertson, J., Levy, A., Sagripanti, J.L. e Inglis, T.J.J., “The survival of Burkholderia pseudomallei in liquid media”, Am J Trop Med Hyg, 2010, 82: 88-94.

  21. Peacock, S.J., Schweizer, H.P., Dance, D.A., Smith, T.L., Gee, J.E., Wuthiekanun, V. et al., “Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei”, Emerg Infect Dis, 2008, 14: e2.

  22. John, T.J., Jesudason, M.V., Lalitha, M.K., Ganesh, A., Mohandas, V., Cherian, T. et al., “Melioidosis in India: the tip of the iceberg?”, Indian J Med Res, 1996, 103: 62-65.

  23. Ngauy, V., Lemeshev, Y., Sadkowski, L. y Crawford, G., “Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II”, J Clin Microbiol, 2005; 43: 970-972.

  24. Kibbler, C.C., Roberts, C.M., Ridgway, G.L. y Spiro, S.G., “Melioidosis in a patient from Bangladesh”, Postgrad Med J, 1991, 67: 764-766.

  25. Pumpuang, A. et al., “Survival of Burkholderia pseudomallei in distilled water for 16 years”, Trans R Soc Trop Med Hyg, 2011, 105: 598-600.

  26. Gal, D. et al., “Contamination of hand wash detergent linked to occupationally acquired meliodosis”, Am J Trop Med Hyg, 2004, 71: 360-362.

  27. Dejsirilert, S., Kondo, E., Chiewsilp, D. y Kanai, K., “Growth and survival of Pseudomonas pseudomallei in acidic environments”, Jpn J Med Sci Biol, 1991, 44: 63-74.

  28. Chen, Y.S., Chen, S.C., Kao, C.M. y Chen, Y.L., “Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei”, Folia Microbiol, 2003, 48: 253-256.

  29. Ainsworth, R. (ed.), Safe piped water: managing microbial water quality in piped distribution systems, Londres- Ginebra, iwa Publishing-Organización Mundial de la Salud, Londres-Ginebra, 2004.

  30. Currie, B.J., Fisher, D.A., Howard, D.M., Burrow, J.N., Selvanayagam, S., Snelling, P.L., Anstey, N.M. y Mayo, M.J., “The epidemiology of melioidosis in Australia and Papua New Guinea”, Acta Trop, 2000, 74 (2-3): 121-127.

  31. Currie, B.J. et al., “A cluster of melioidosis cases from an endemic region is clonal and is linked to the water supply using molecular typing of Burkholderia pseudomallei isolates”, Am J Trop Med Hyg, 2001, 65: 177-179.

  32. Inglis, T.J. et al., “Outbreak strain of Burkholderia pseudomallei traced to water treatment plant”, Emerg Infect Dis, 2000, 6: 56-59.

  33. Dance, D.A., Wuthiekanun, V., Naigowit, P. y White, N.J., “Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and api 20ne”, J Clin Pathol, 1989, 42: 645-648.

  34. Limmathurotsakul, D., Jamsen, K., Arayawichanont, A., Simpson, J.A., White, L.J., Lee, S.J. et al., “Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models”, plos One, 2010, 5: e12485.

  35. Roesnita, B., Tay, S.T., Puthucheary, S.D. y Sam, I.C., “Diagnostic use of Burkholderia pseudomallei selective media in a low prevalence setting”, Trans R Soc Trop Med Hyg, 2012, 106: 131-133.

  36. Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P., Limmathurotsakul, D. et al., “Monoclonal antibody-based immunofluorescence microscopy for the rapid identification of Burkholderia pseudomallei in clinical specimens”, Am J Trop Med Hyg, 2013, 89: 165-168.

  37. Wongsuvan, G., Limmathurotsakul, D., Wannapasni, S., Chierakul, W., Teerawattanasook, N. y Wuthiekanun, V., “Lack of correlation of Burkholderia pseudomallei quantities in blood, urine, sputum and pus”, Southeast Asian J Trop Med Public Health, 2009, 40: 781-784.

  38. Dance, D.A., Wuthiekanun, V., Naigowit, P. y White, N.J., “Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and api 20ne”, J Clin Pathol, 1989, 42: 645-648.

  39. Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P., Limmathurotsakul, D. et al., “Monoclonal antibody-based immunofluorescence microscopy for the rapid identification of Burkholderia pseudomallei in clinical specimens”, Am J Trop Med Hyg, 2013, 89: 165-168.

  40. Inglis, T.J., Chiang, D., Lee, G.S. y Chor-Kiang, L., “Potential misidentification of Burkholderia pseudomallei by api 20ne”, Pathology, 1998, 30: 62-64.

  41. Lowe, P., Engler, C. y Norton, R., “Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2002, 40: 4625-4627.

  42. Inglis, T.J., Merritt, A., Chidlow, G., Aravena-Roman, M. y Harnett, G., “Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2005, 43: 2201-2206.

  43. Dickinson, B., “BD Phoenix system user’s manual”, document L003342(M), Becton Dickinson and Company, Sparks, MD, 2005.

  44. BioMérieux, “Vitek 2 product information”, document 510769-4EN1, BioMérieux, Inc., Durham, NC, 2006.

  45. Glass, M.B. y Popovic, T., “Preliminary evaluation of the api 20ne and Rapid nf plus systems for rapid identification of Burkholderia pseudomallei and B. mallei”, J Clin Microbiol, 2005, 43: 479-483.

  46. Amornchai, P., Chierakul, W., Wuthiekanun, V., Mahakhunkijcharoen, Y., Phetsouvanh, R., Currie, B.J. et al., “Accuracy of Burkholderia pseudomallei identification using the api 20ne system and a latex agglutination test”, J Clin Microbiol, 2007, 45: 3774-3776.

  47. Koh, T.H., Yong, Ng, L.S., Foon Ho, J.L., Sng, L.H., Wang, G.C. y Tzer Pin Lin, R.V., “Automated identification systems and Burkholderia pseudomallei, J Clin Microbiol, 2003, 41: 1809.

  48. Weissert, C., Dollenmaier, G., Rafeiner, P., Riehm, J. y Schultze, D. “Burkholderia pseudomallei misidentified by automated system”, Emerg Infect Dis, 2009, 15: 1799-1801.

  49. Lowe, P., Haswell, H. y Lewis, K., “Use of various common isolation media to evaluate the new Vitek 2 colorimetric gn card for identification of Burkholderia pseudomallei”, J Clin Microbiol, 2006, 44: 854-856.

  50. Zong, Z., Wang, X., Deng, Y. y Zhou, T., “Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the Vitek 2 system”, J Med Microbiol, 2012, 61: 1483- 1484.

  51. Podin, Y., Kaestli, M., McMahon, N., Hennessy, J., Ngian, H.U., Wong, J.S, et al., “Reliability of automated biochemical identification of Burkholderia pseudomallei is regionally dependent”, J Clin Microbiol, 2013, 51: 3076-3078.

  52. Hodgson, K., Engler, C., Govan, B., Ketheesan, N. y Norton, R., “Comparison of routine bench and molecular diagnostic methods in identification of Burkholderia pseudomallei”, J Clin Microbiol, 2009, 47: 1578-1580.

  53. Podin, Y., Sarovich, D.S., Price, E.P., Kaestli, M., Mayo, M., Hii, K. et al., “Burkholderia pseudomallei isolates from Sarawak, Malaysian Borneo, are predominantly susceptible to aminoglycosides and macrolides”, Antimicrob Agents Chemother, 2014, 58: 162-166.

  54. Anuntagool, N., Naigowit, P., Petkanchanapong, V., Aramsri, P., Panichakul, T. y Sirisinha, S., “Monoclonal antibodybased rapid identification of Burkholderia pseudomallei in blood culture fluid from patients with community-acquired septicaemia”, J Med Microbiol, 2000, 49: 1075-1078.

  55. Cheng, A.C., O’Brien, M., Freeman, K., Lum, G. y Currie, B.J., “Indirect hemagglutination assay in patients with melioidosis in northern Australia”, Am J Trop Med Hyg, 2006, 74: 330-334.

  56. Cheng, A.C., Peacock, S.J., Limmathurotsakul, D., Wongsuvan, G., Chierakul, W., Amornchai, P. et al., “Prospective evaluation of a rapid immunochromogenic cassette test for the diagnosis of melioidosis in northeast Thailand”, Trans R Soc Trop Med Hyg, 2006, 100: 64-67.

  57. Harris, P.N., Ketheesan, N., Owens, L. y Norton, R.E., “Clinical features that affect indirect-hemagglutination-assay responses to Burkholderia pseudomallei”, Clin Vaccine Immunol, 2009, 16: 924-930.

  58. Chantratita, N., Tandhavanant, S., Wongsuvan, G., Wuthiekanun, V., Teerawattanasook, N., Day, N.P. et al., “Rapid detection of Burkholderia pseudomallei in blood cultures using a monoclonal antibody-based immunofluorescent assay”, Am J Trop Med Hyg, 2013, 89: 971-972.

  59. Wuthiekanun, V., Desakorn, V., Wongsuvan, G., Amornchai, P., Cheng, A.C., Maharjan, B. et al., “Rapid immunofluorescence microscopy for diagnosis of melioidosis”, Clin Diagn Lab Immunol, 2005, 12: 555-556.

  60. Ortega, G.M.V. et al., “pcr cuantitativa en tiempo real para la amplificación de adn de Burkholderia mallei: comparación con el método molecular recomendado por la oie”, Said Mil, 2017, 73 (2): 85-90.

  61. Tomaso, H., Scholz, H.C., Al Dahouk, S., Eickhoff, M., Treu, T.M. et al., “Development of a 59-nuclease realtime pcr assay targeting flip for the rapid identification of Burkholderia mallei in clinical samples”, Clin Chem, 2006, 52: 307-310.

  62. Ordóñez, R.I., Otero, M.F., Arias, G.E., Pérez, G.E. y Corcuera, D.C., “Choque séptico por Burkholderia multivorans en paciente previamente sano a su ingreso hospitalario. Presentación de un caso y revisión de la literatura”, trabajo libre presentado en el XXXV Congreso de Infectología Pediátrica, Asociación Mexicana de Infectología Pediátrica, Veracruz 2016.

  63. Gilad, J., Schwartz, D. y Amsalem, Y., “Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia Mallei and Burkholderia pseudomallei”, Inter J Biomed Science, 2007, 3 (3): 144-152.




2020     |     www.medigraphic.com